Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Hypertension. 2014 Jun 23;64(4):801–807. doi: 10.1161/HYPERTENSIONAHA.114.03609

TABLE 1.

Baseline body weights, systolic BP, proteinuria and final body weights and proteinuria

Baseline Final at 4 weeks
Group (n) Body weight
(g)		 Systolic BP
mmHg		 Proteinuria
mg/24h		 Body weight
(g)		 Proteinuria
mg/24h
1% NaCl (27) 244 ± 4.7 171.5 ± 1.8 7.3 ± 0.8 261 ± 6.7 115.5 ± 12.8
1% NaCl (15) + enalapril 262 ± 5.4 176.2 ± 2.2 5.6 ± 0.4 301* ± 2.7 24.3* ± 3.1
1% NaCl (15) + H&H 249 ± 4.6 173.6 ± 2.1 6.8 ± 0.7 295* ± 5.0 14.1* ± 0.9
1% NaCl (13) + amlodipine 247 ± 6.1 175.3 ± 2.1 6.2 ± 0.6 282 ± 6.2 22.2* ± 2.4

Footnote: H&H – a combined antihypertensive regimen of hydralazine and hydrochlorothiazide

*

p < 0.05 vs. the untreated 1% NaCl only group. The final data at 4 weeks for the untreated 1% NaCl groups includes data obtained from 6 rats before the 4 weeks who were euthanized for humane reasons between the 3rd and 4th week.